RBC Raises Price Target on DocuSign to $70 From $55, Keeps Sector Perform Rating

RBC increased its price target on DocuSign to $70 from $55, according to the company. The firm maintained its 'Sector Perform' rating. DocuSign's stock has seen a 3.40% increase year-to-date and a 3.55% decrease over 5 days.

Original reporting
Published Sep 4, 2026, 10:27 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 12:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$DOCU
Bullish
medium confidence
Mentioned
$DOCU
Relevance
7/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$DOCUBullishMed
01

Why it matters

Analyst price target changes can influence short‑term trading activity and set a new reference point for investors.

02

Market read

The upgrade may prompt buying interest in DOCU and affect related SaaS stocks.

03

What to watch

Potential competitive pressure from larger players and macro‑economic slowdown.

Relevance 7/10Novelty 6/10Timing: pre-market

Background

RBC's research note updates valuation and EPS revision composites, leading to a higher price target.

Company-level read

Ticker impact

$DOCUBullishMedium confidence
Context

RBC raised DocuSign's price target to $70 from $55, indicating a bullish outlook.

Expected impact

Potential short-term upside as investors adjust expectations.

Evidence & confidence

Price target increase reflects improved valuation metrics; market may react positively.

Market effects

May lift sentiment for the e‑signature and broader SaaS sector.

Limited to U.S. markets where DocuSign trades.

Minimal global impact beyond sector peers.

Counterpoint

Target raise could be premature if upcoming earnings miss expectations.

Key entities

  • RBC Capital Markets

    Provides equity research and price target updates.

  • DocuSign, Inc.

    Provider of electronic signature solutions.

Related articles

$DOCUHighAI 8/10

DOCU Q2 Deep Dive: AI Platform Expansion and Margin Gains Shape Outlook

DocuSign (DOCU) reported Q2 2026 revenue of $875.7M, up 9.4% YoY, beating estimates. Non-GAAP EPS was $1.16, 6.8% above consensus. The company expects Q3 revenue around $888M. Growth was driven by its Intelligent Agreement Management (IAM) platform, which now accounts for 15.1% of total annual recurring revenue. Management highlighted AI-driven features and operational discipline as key factors.

$LULUHighAI 8/10

Stocks making the biggest moves after hours: Lululemon, Zscaler, Guidewire Software & more

Lululemon (LULU) fell 18% after weak Q3 guidance. Docusign (DOCU) rose 4% on earnings beat. Zscaler (ZS) gained 2% with strong Q4 results. Adobe (ADBE) dropped 1% on CEO transition. Planet Labs (PL) advanced 7% on Q2 earnings. Asana (ASAN) fell 10% on Q3 guidance. Guidewire (GWRE) dropped 15% on revenue outlook. Samsara (IOT) surged 14% on raised guidance. UiPath (PATH) lost 7% on Q3 outlook.

$DOCUHighAI 8/10

Expected Sales In Q2 CY2026, Stock Soars

DocuSign (DOCU) reported Q2 CY2026 revenue of $875.7M, up 9.4% YoY, exceeding estimates. Non-GAAP EPS was $1.16, 6.8% above consensus. The company expects Q3 revenue of $888M, close to analyst estimates. CEO Allan Thygesen attributed growth to AI-driven momentum. Despite recent slowdowns, the stock rose 7.7% post-results.

$IOTHighAI 8/10

After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM

Samsara (IOT) rose 11% on strong Q2 results and raised guidance. UiPath (PATH) climbed 13% with solid Q2 revenue and upbeat full-year outlook. Docusign (DOCU) gained 7% after a beat-and-raise Q2 report. Asana (ASAN) fell 12% on soft near-term profitability targets. Guidewire (GWRE) dropped 19% due to weak Q1 revenue guidance. Zscaler (ZS) edged up 1% on solid fiscal Q4 results. Planet Labs (PL) jumped 5% after reporting a surprise Q2 profit. Smith & Wesson (SWBI) surged 8.6% on strong Q1 sales.